LOM
SCR

Loeb Offshore Management’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Loeb Offshore Management’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,575
Closed -$488K – 284
2013
Q4 		$488K Buy
+50,575
New +$480K 0.13% 124

Loeb Offshore Management's SCR Position: Q1 2014 in Review

Loeb Offshore Management sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 50,575 shares — an estimated $488K sold.

Loeb Offshore Management first reported a position in SCR in Q4 2013 and held it in 1 quarter. The position peaked at $488K in Q4 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Loeb Offshore Management reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Loeb Offshore Management sold 50,575 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $488K.
  • Loeb Offshore Management first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q4 2013 and held it in 1 quarter.
  • Loeb Offshore Management's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $488K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Loeb Offshore Management's 13F filing for Q1 2014, filed 15 May 2014.